glp 1 2026 The Medicare GLP-1 Bridge Begins July 1, 2026: What Our Patients Need to Know GLP-1 in 2026: The New
Description
GMP Certified
Not Applied to the Mouth or LipsThis product is not used on the mouth, does not close the lips, and is not intended for breathing modification.
Pfizer is developing a long-acting GLP-1 drug that could compete directly with Eli Lilly's Mounjaro and Zepbound when it reaches the Canadian market.
Results vary.
85% reduced fast food cravings
Millions of people seeking weight loss now have access to GLP-1 medications through telehealth platforms
